Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $8.3 million.

  • Celularity's Current Deferred Revenue rose 3183.83% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 3183.83%. This contributed to the annual value of $6.3 million for FY2024, which is 390.37% up from last year.
  • According to the latest figures from Q3 2025, Celularity's Current Deferred Revenue is $8.3 million, which was up 3183.83% from $6.4 million recorded in Q2 2025.
  • Celularity's 5-year Current Deferred Revenue high stood at $8.3 million for Q3 2025, and its period low was $3.8 million during Q3 2021.
  • Its 5-year average for Current Deferred Revenue is $5.4 million, with a median of $5.6 million in 2023.
  • In the last 5 years, Celularity's Current Deferred Revenue plummeted by 6733.07% in 2021 and then skyrocketed by 3419.54% in 2024.
  • Celularity's Current Deferred Revenue (Quarter) stood at $4.1 million in 2021, then rose by 10.45% to $4.5 million in 2022, then skyrocketed by 34.02% to $6.0 million in 2023, then rose by 3.9% to $6.3 million in 2024, then surged by 33.46% to $8.3 million in 2025.
  • Its last three reported values are $8.3 million in Q3 2025, $6.4 million for Q2 2025, and $6.3 million during Q1 2025.